Kelly E. Craven

605 total citations
15 papers, 441 citations indexed

About

Kelly E. Craven is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Kelly E. Craven has authored 15 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Kelly E. Craven's work include Pancreatic and Hepatic Oncology Research (6 papers), Cancer Cells and Metastasis (5 papers) and Cancer Genomics and Diagnostics (3 papers). Kelly E. Craven is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Cancer Cells and Metastasis (5 papers) and Cancer Genomics and Diagnostics (3 papers). Kelly E. Craven collaborates with scholars based in United States, Slovakia and Israel. Kelly E. Craven's co-authors include Murray Korc, Jesse Gore, Sunil Badve, Yesim Gökmen‐Polar, Lakshmi Reddy Palam, Monica Cheng, A. Jesse Gore, Abass M. Conteh, Poornima Bhat‐Nakshatri and Chirayu Goswami and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Scientific Reports.

In The Last Decade

Kelly E. Craven

15 papers receiving 437 citations

Peers

Kelly E. Craven
Kelly E. Craven
Citations per year, relative to Kelly E. Craven Kelly E. Craven (= 1×) peers Brunella Costanza

Countries citing papers authored by Kelly E. Craven

Since Specialization
Citations

This map shows the geographic impact of Kelly E. Craven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly E. Craven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly E. Craven more than expected).

Fields of papers citing papers by Kelly E. Craven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly E. Craven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly E. Craven. The network helps show where Kelly E. Craven may publish in the future.

Co-authorship network of co-authors of Kelly E. Craven

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly E. Craven. A scholar is included among the top collaborators of Kelly E. Craven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly E. Craven. Kelly E. Craven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Kadri, Sabah, Kelly E. Craven, Elaine P.S. Gee, et al.. (2025). Clinical Bioinformatician Body of Knowledge—Bioinformatics and Software Core. Journal of Molecular Diagnostics. 27(7). 566–582. 2 indexed citations
2.
Craven, Kelly E. & Mark D. Ewalt. (2023). Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance). Clinics in Laboratory Medicine. 43(4). 565–576. 3 indexed citations
3.
Craven, Kelly E., Catherine G. Fischer, Liqun Jiang, et al.. (2022). Optimizing Insertion and Deletion Detection Using Next-Generation Sequencing in the Clinical Laboratory. Journal of Molecular Diagnostics. 24(12). 1217–1231. 13 indexed citations
4.
Craven, Kelly E., Yesim Gökmen‐Polar, & Sunil Badve. (2021). CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer. Scientific Reports. 11(1). 4691–4691. 84 indexed citations
5.
Craven, Kelly E., David W. Nauen, Mark Yarchoan, et al.. (2020). Rapidly progressive metastatic cholangiocarcinoma in a postpartum patient with cystic fibrosis: a case report. BMC Pulmonary Medicine. 20(1). 3 indexed citations
6.
Gore, Jesse, et al.. (2016). Combined targeting of TGF-beta, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model. PMC. 1 indexed citations
7.
Gore, Jesse, et al.. (2016). Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model. Cancer Letters. 379(1). 143–153. 35 indexed citations
9.
Craven, Kelly E., Chirayu Goswami, Sunil Badve, et al.. (2015). Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells. PubMed Central. 1 indexed citations
10.
Craven, Kelly E., Jesse Gore, & Murray Korc. (2015). Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma. Cancer Letters. 381(1). 201–210. 41 indexed citations
11.
Craven, Kelly E., et al.. (2015). Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes. Oncotarget. 7(1). 323–341. 33 indexed citations
12.
Craven, Kelly E., Chirayu Goswami, Sunil Badve, et al.. (2015). Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells. Oncotarget. 6(14). 12682–12696. 47 indexed citations
13.
Palam, Lakshmi Reddy, et al.. (2015). Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma. Cell Death and Disease. 6(10). e1913–e1913. 87 indexed citations
14.
Gore, Jesse, Kelly E. Craven, Gregory A. Coté, et al.. (2015). TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesis. Oncotarget. 6(10). 7504–7521. 39 indexed citations
15.
Gore, A. Jesse, et al.. (2013). Pancreatic cancer–associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation. Journal of Clinical Investigation. 124(1). 338–352. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026